2016 International Congress

Tuesday, June 21, 2016

12:30pm-2:00pm

α-synuclein CSF levels correlate with urinary dysfunction in early de novo Parkinson’s disease patients

G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

α-synuclein in peripheral organs decreases in Lewy body disease complicated by Alzheimer’s disease

H. Sumikura, J. Fujigasaki, Y. Nakano, A. Uchino, Y. Saito, H. Mochizuki, S. Murayama (Tokyo, Japan)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

"Are patients with familial ET distinct from those with sporadic ET? Insight from 250 patients"

M. Manjunath, A. Lenka, K. Jhunjhunwala, K.S. Bhalsing, P.K. Pal (Bengaluru, India)

Tremor  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

DYT2 screening in early-onset isolated dystonia in Italy

C. Reale, F. Invernizzi, M. Carecchio, S. Petrucci, G. Zorzi, F. Zibordi, M. Ginevrino, E.M. Valente, N. Nardocci, B. Garavaglia (Milan, Italy)

Genetics (NON-PD)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

SLC6A17 mutations are not a common cause of intellectual disability and movement disorders in a large cohort of consanguineous Iranian families

I.A. Meijer, L.J. Azcona, H. Darvish, C. Paisán-Ruiz (New York, NY, USA)

Genetics (NON-PD)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

1 to 40 years later: Delayed effects of brain radiation presenting as parkinsonism

R. Mehanna, J. Jimenez-Shahed, I. Itin, R. Mehanna (Houston, TX, USA)

Drug-induced movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

A 12-month, 2-arm, 2-period, randomized, controlled trial of a digital solution for the management of Parkinson’s disease (PD): Rationale and study design

S. Papapetropoulos, G. Mitsi (Boston, MA, USA)

Technology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

A clinico-genetical study in a large cohort of patients with spastic paraplegia type 4 (SPG4)

A. Orlacchio, M. Mearini, L. Pedace, A. Casella, C. Montecchiani, F. Gaudiello, M. Maurialuisa, R. Massa, C. Caltagirone, R.P. Munhoz, J.L. Pedroso, O.G.P. Barsottini, T. Kawarai (Rome, Italy)

Genetics (NON-PD)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

A comparative study of clinical profile of patients of drug induced parkinsonism with idiopathic Parkinson’s disease

S. Kushwaha, R. Mistry, A. Anthony, S. Khurana (Delhi, India)

Hyperkinetic Movement Disorders, RLS, Sleep

12:30pm-2:00pm

A comprehensive characterisation of the salivary proteome of patients with Parkinson’s disease

J.M. Masters, A.J. Noyce, S. Lynham, T.T. Warner, G. Giovannoni, G.B. Proctor (Herts, United Kingdom)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2